Evidence map›Paper›PMID 37697053›Full record

SynthesisInternational journal of impotence research2024

Do "testosterone boosters" really increase serum total testosterone? A systematic review.

Afonso Morgado, Georgios Tsampoukas, Ioannis Sokolakis, Nadja Schoentgen, Ahmet Urkmez, Selcuk Sarikaya

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in International journal of impotence research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 6 countries.

Afonso MorgadoServiço de Urologia, Centro Hospitalar Universitário São João, Porto, Portugal. luisafonsomorgado@gmail.com.ORCID http://orcid.org/0000-0002-9647-4360
Georgios TsampoukasDepartment of Urology, Oxford University Hospital NHS Trust, Oxford, UK.
Ioannis Sokolakis2nd Department of Urology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.ORCID http://orcid.org/0000-0002-1938-8004
Nadja SchoentgenUrology Department, University Hospital Center Bichat Claude Bernard, Paris, France.
Ahmet UrkmezDepartment of Urology, St. Elizabeth's Medical Center, Boston, MA, USA.ORCID http://orcid.org/0000-0001-8357-7734
Selcuk SarikayaDepartment of Urology, Gülhane Research and Training Hospital, Ankara, Turkey.ORCID http://orcid.org/0000-0001-6426-1398
Aristotle University of Thessaloniki · GRGülhane Askerî Tıp Akademisi · TRHospital de São João · PTOxford University Hospitals NHS Trust · GBSt. Elizabeth's Medical Center · USUniversité Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Testosterone boosters are heavily marketed on social media and marketplaces to men with claims to significantly increase testosterone. Lax industry regulation has allowed sales of supplements to thrive in the absence of verification of their purported benefits. Our primary objective was to systematically review all data published in the last two decades on testosterone boosters and determine their efficacy. Our outcome of interest was total testosterone increase versus placebo in four different populations: male athletes, men with late-onset hypogonadism infertile men and healthy men. Following search and screening, 52 studies were included in our review, relating to 27 proposed testosterone boosters: 10 studies of cholecalciferol; 5 zinc/magnesium; 4 Tribulus terrestris and creatine; 3 Eurycoma longifolia and Withania somnifera; 2 betaine, D-aspartic acid, Lepidium meyenii and isoflavones; while the remainder were single reports. Our findings indicate that most fail to increase total testosterone. The exceptions were β-hydroxy β-methylbutyrate and betaine, which can be considered effective for male athletes. Eurycoma longifolia, a blend of Punica granatum fruit rind and Theobroma cacao seed extracts (Tesnor

Indexed as

Dietary SupplementsTestosteroneAthletesCreatineHumansHypogonadismInfertility, MaleMalePlant ExtractsTribulusCreatinePlant ExtractsTestosterone

Identifiers

PMID37697053
OpenAlexW4386599797

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.